The Return of Silver in Medicine: Colloidal Silver, Nature's Alternative to Antibiotics

Health Newsline
In the early 1900's an antibacterial solution called Colloidal Silver became the choice of medical practitioners. It proved to be enormously effective against infectious organisms and extremely safe to use, without the negative side effects associated with drugs. But Colloidal Silver became increasingly expensive and the pharmaceutical companies developed antibiotics as we know them today. Silver took a back seat. However, as usual, as we deviate from nature, unforeseen problems develop. Forty years after the advent of antibiotics, many types of disease-causing organisms had built an immunity to their action.

Over the years the medical establishment has reported on the new strains of "Super Bugs" that cannot be destroyed by antibiotics. Newsweek Magazine reported in March 28, 1994 that in 1992, 13,000 hospital patients died of infections that resisted every drug doctors tried. Also a well known fact is the detrimental effect of antibiotics on the naturally occurring flora in the colon. Colloidal Silver does not disturb this very necessary environment.

Fortunately, the timely re-emergence of Colloidal Silver due to new technology and much reduced costs in production, may prove to be one of the best remedies that the public now has to protect themselves.

"And now it's silver that is finding wholly new uses as a wonder in modern medicine...perhaps it soon will be recognized as OUR MIGHTIEST GERM FIGHTER." (Science Digest, March 1978.) Silver is considered to be one of the most universal antibiotic substances known. Jim Powell reported in the Science Digest article quoted above, that an antibiotic kills perhaps 7 different disease organisms, but silver kills some 650. Resistant strains fail to develop. Moreover, silver is non-toxic!

The comeback of silver in medicine began in the 1970's. The late Dr. Carl Moyer, chairman of Washington University's Department of Surgery, received a grant to develop better treatment for burn victims. Dr. Harry Margraf of St. Louis, as the chief biochemist, worked with Dr. Moyer and other surgeons to find an antiseptic strong enough, yet safe, to use over larger areas of the body. Dr. Margraf reviewed 22 antiseptic compounds and found drawbacks in all of them. (SILVER IS USED IN ALL MAJOR BURN CENTERS IN THE UNITED STATES. UCLA MEDICAL LABS FOUND IT EFFECTIVE ON EVERY VIRUS THEY TESTED IT ON.)

He noted that many of these antibiotics were ineffective against a number of harmful bacteria, including the biggest killer in burn cases - greenish blue bacterium called Pseudomonas acruginose. Extensive trials proved silver to be the most effective and is currently used in all major burn centers in the United States.

In 1834, the German obstetrician F. Crede administered 1% silver nitrate to the eyes of newborn infants, virtually eliminating the incidence of disease causing blindness in newborn babies. however, it was not until the late 1800's that Western scientists were able to prove what had been known in Eastern medicine for thousands of years...that silver was a proven germ fighter! Once the discovery was made that the body's chief fluids were colloidal in nature, the endless possibilities which could occur from the use of colloids in medicine were recognized. As a result, a silver solution known as Colloidal Silver became widely used in medicine as one of the main-stays of antimicrobial treatment, until money became an issue. "What we actually have done, was rediscover that silver kills bacteria", stated Dr. Robert Becker M. D. "It is non-toxic in micro-concentrations of 3-5 parts per million."

 

BIBLIOGRAPHY

1.World Health Organization, Guidelines for drinking-water quality, Silver in drinking water, Geneva, 2003.
2.EPA, Integrated Risk Information System, Silver (CASRN 7440-22-4) 1996.
3.Uljanov J.P. Ph.D., Head of ORL Clinic “Agami” Moscow, “Silver dependent people among us” (original and translation), 2003.
4.Report on “Mercana” company’s product “Silver prince”, Russia, 2004.
5.World Health Organization, Chemical hazards in drinking-water – silver, Geneva, 2003.
6.Eichorn, Gunter, et. al., Interaction of Metal Ions and Biological Systems, with special reference to Silver and Gold, Proceedings of the first International Conference on Gold and Silver in Medicine, pg 3-22, The Gold and Silver Institutes, Suite 101, 1026 16th St., N.W., Washington, D.C. 2003.
7.Flick, A.B., Clinical Application of Electrical Silver Iontophoresis, Proceedings of the First International Conference on Gold and Silver in Medicine, pg 273-276, The Gold and Silver Institutes, Suite 101, 1026 16th St., N.W., Washington, D.C. 2003.
8.Williams, D.F., The Biocompatibility of Silver, Proceedings of the First International Conference on Gold and Silver in Medicine, pg 261-272, The Gold and Silver Institutes, Suite 101, 1026 16th St., N.W., Washington, D.C. 2003.
9.Spardo, J.A., Silver Anode Inhibition of Bacteria, Proceedings of the First International Conference on Gold and Silver in Medicine, pg 245-260, The Gold and Silver Institutes, Suite 101, 1026 16th St., N.W., Washington, D.C. 2003.
10.Uljanov J.P. Ph.D., “Three characteristics of silver”, 2003.
11.Neimark A.I., Davydov A.V., Lebedev E.V. “Silver-containing hydrocarbonate-calcium-magnesium mineral water in complex treatment of patients with chronic pyelonephritis”, 2003.
12.Li ZH, Liu CL, Yu XY, Xie LQ, Institute of Space meico-Engineering, Beijing, China, “Effects of head down bed rest or drinking water containing electrolytic silver-ion on intestinal bifidobacteria”, June, 2002.
13.Becker, Robert O., Effects of Electrically Generated Silver Ions on Human Cells and Wound Healing, Electro and Magnetobiology, 19(1), 1-19, 2000.
14.Agency for Toxic Substances and Disease Registry, ToxFAQs for Silver, July 1999.
15.Altman, Roger, Eng. Sc. D., Colloidal Silver. Where does it go when you drink it? How long does it stay there?, 1999, rogaltman@aol.com.
16.Gibbs, Ronald J., Silver Colloids – Do they Work? ISBN: 0967699207, 1999.
17.(87) Maki D.G., Stolz S.M., Wheeler A., Mermel L.A., Prevention of Central Venous Catheter-Related Blookstream Infection by Use of an Antiseptic-Impregnated Catheter, Am College of Physicians, 127(4):257-266, Aug 5, 1997.
18.World Health Organization, Guidelines for drinking-water quality, silver in drinking water, Geneva, 1996.
19.EPA, Integrated Risk Information System, Silver (CASRN 7440-22-4) 1996.
20.Federal Register Vol. 61, No. 200 Tuesday, October 15, 1996 Proposed Rules 53685, 21 CFR Part 310 [Docket No. 96N-0144] Over-the-Counter Drug Products Containing Colloidal Silver ingredients or Silver Salts.
21.Federal Register Vol. 61, No. 200 Tuesday, October 15, 1996 Proposed Rules 53685, 21 CFR Part 310 [Docket No. 96N-0144] Over-the-Counter Drug Products Containing Colloidal Silver ingredients or Silver Salts.
22.Fung, Man C., & Bowen, Debra L., Journal of Toxicology: Clinical Toxicology, Jan 1996, V34 N1, p119(8
23.Nand S. Sengar G.K., Nand S., Jain V.K., Gupta T.D., Dual Use of Silver for A Management of Chronic Bone Infections and Infected Non-Unions, J. Indian Medical Assoc, 84:134-136, 1996.
24.Nand S. Sengar G.K., Nand S., Jain V.K., Gupta T.D., Dual Use of Silver for A Management Bellavite, Paolo, M.D. & Signorini, M.D., HOMEOPATHY: A Frontier in Medical Science, North Atlantic Books, 1995 ISBN 1-55643-211-9.
25.American Metal Market, “Silver Compound Aids in Bacterial Defense”, Feb.10, 1995, V 103, n 28.
26.Colloidal Silver Proteins Marketed as Health Supplements, Journal of the American Medical Association, JAMA October 18, 1995 – Vol. 274, No. 15
27.FDA Background Statement on Colloidal Silver, Received Sept. 13, 1995.
28.Farber, Paul M., N.D., D.C., PhD., The Micro Silver Bullet, 1995, ISBN 1-887742-00-X
29.Schiff, Michael, The Memory of Water, Thorsons, 1995, ISBN 0 7225 3262 8
30.Sheridan R., Doherty P.J. Gilchrist T., Healy D., The Effect of antibacterial agents on the behaviour of Cultured Mammalian Fibroblasts., J. of Materials Science, 6:853-856, 1995.
31.Bach A., Boher H., Motsch J., Martin E., Geiss H.K., Sonntag H.G., Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers J of Antimicrob Chem., 33:969-978, 1994.
32.Clement J.L., Jarret P.S., Antibacterial Silver Metal Based Drugs 1(5-6):467-482, 1994.
33.Schmidt, Michael A., Lendon H. Smith (Contributor), Keith W. Sehnert (Contributor), Beyond Antibiotics: Boost Your Immunity and Avoid Antibiotics by North Atlantic Books, 1994, ISBN: 1556431805
34.Tichy, Daryl, Daryl Tichy Updates, A newsletter published 349 North 250 East, Orem, Utah 84057, Several issues from 1994-1996.
35.Mackay, Raymond A., and John Texter, Electrochemistry in Colloids and Dispersions, VCH Publishers, Inc., 1992, ISBN 1-56081-573-6
36.Hussain, Saber; Anner, Rolf M.; & Anner, Beatrice M.; Cystine protects Na,K-ATPase and isolated human lymphocytes from silver toxicity, Biochemical and Biophysical Research Communications, vol. 189, No. 3 Dec.30, 1992, pp, 1444-1449.
37.Simonetti, N., Simonetti, G., Bougnol, F., and Scalzo, M. (1992) Electrochemical Ag+ for preservative use. Article found in Applied and Environmental Microbiology. American Society for Microbiology: Washington, V.58, 12, pp. 3834-3836.
38.Slawson, R.M., Van dyke, M.I., Lee, H. and Trevors, J.T. (1992) Germanium and Silver resistance, accumulation and toxicity in microorganisms. Article found in Plasmid. Academic Press, Inc., San Diego, V. 27, 1, pp. 73-79.
39.Svoboda, Robert E., Ayurveda Life, Health and Longevity, Penguin Books, 1992.
40.Chu C.S., McManus A.T., Okerberg C.V., Mason A.D., Pruitt B.A. Weak Direct Current Accelerates Split-thickness Graft Healing on Tangentially Excised Second-degree Burns J of Burn Care Rehab, 12:285-293, 1991.
41.Chu C.S., McManus A.T., Okerberg C.V., Mason A.D., Pruitt B.A. Multiple Graft Harvestings from Deep Partial-thickness Scald Wounds Healed under the Influence of Weak Direct Current Journal of Trauma, 30:1044, 1990.
42.Direct Current Reduces Wound Edema After Full Thickness Burn Injury in Rats Journal of Trauma, Injury, Infection & Critical Care, 400 (5):738, 1990.
43.Moyasar, T.Y., Landeen, L.K., Messina, M.C., Kuta, S.M. Schulze, R., and Gerba, C.P., (1990), Disinfection of Bacteria in Water systems by using electrolytically generated copper-silver and reduced levels of free chlorine. Found in the Canadian Journal of Microbiology. The National Research Council of Canada: Ottawa, Ont. Canada, pp. 109-116.
44.Thurman, R.B., and Gerba, C.P. (1989). The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses. CRC Critical Reviews in Environmental Control, V. 18, 4, p. 295, 299, 301, 302.
45.Williams R.L., Doherty P.J., Vince D.G., Grashoff G.J., Williams D.F., The Biocompatibility of Silver, Critical Reviews in Biocompatibility, 5:221, 1989.
46.Chu C.S., McManus A.T., Okerberg C.V., Mason A.D., Therapeutic Effects of Silver Nylon Dressings with Weak Direct Current on Pseudomonas aeruginosa-infected Burn Wounds, The Journal of Trauma, 28(10):1488-1492, 1988.
47.Maki D.G., Garman J.K., Shapiro J.M., Ringer M., Helgerson R.B., An Attachable Silver-Impregnated Cuff for Prevention of Infection with Central Venous Catheters: A Prospective Randomized Multicenter Trial Attachable Silver, Am J of Med, 85:307-314, 1998.
48.Chu C.C., Tsai W.C., Yao J.Y., Chiu S.S., Newly made antibacterial braided nylon sutures. 1. In vitro qualitative and in vivo preliminary biocompatibility study, J. Biomed. Material Res., 21:1281, 1987.
49.Greene, R.M., Su, WP Daniel, “Argyria”, American Family Physician, 1987; 36; 151-154
50.Tsai W.C., Chu C.C., Chin S.S., Yao J.Y., In Vitro quantitative study of newly made antibacterial braided nylon sutures, Surg. Gynecol. Obstet., 165:207, 1987.
51.Westhafen, M., Schafer, H., “Generalized Argyrosis in man: Neurological, Ultrastructural and X-ray microanalytical findings”, Archives of Otorhinolaryngology, 1986; 232; 260-264.
52.Doull, J. et. al., Cosaret and Doull’s Toxicology, The Basic Science of Poisons, Third Edition, 1986, p. 625.
53.Becker, Robert O., M.D., William Morrow, The Body Electric, 1985.
54.Marino A.A., Deitch E.A., Albright J.A., Electric Silver Antisepsis, IEEE Trans. Biomed. Eng. BME, 32:336, 1985.
55.Marino A.A., Malakonok V., Albright J.A., Deitch E.A., Specian R.D., Electrochemical properties of silver-nylon fabrics, J. of Electrochem. Soc., 132:68, 1985.
56.Marino A.A., Deitch E.A., Malakonok V., Albright J.A., Specian R.D., Electrical Augmentation of the Antimicrobial Activity of Silver-Nylon Fabrics, J. Biol. Phys., 12:93, 1984.
57.Spadaro J.A., Webster D.A., Kovach D.A., Chase S.E., Antibacterial Fixation Pins with Silver: Animal Models, Trans Orthop. Res. Soc., 9:335, 1984.
58.Deitch E.A., Malakonok V., Albright J.A., Electric Augmentation of the Anti-Bacterial Activity of Silver-Nylon, 3rd Annual BRAGS, 10/2-5/1983.
59.Deitch E.A., Marino A.A., Gillespie T.E., Albright J.A., Silver-Nylon: A New Antimicrobial Agent, Antimicrobial Agents Chemother., 23:356, 1983.
60.Spadaro J.A., Kramer S.J., Webster D.A., Antibacterial demineralized bone matrix using silver, 28th Annual ORS-, N. Orleans, LA, Jan 19-21, 1982.
61.Webster D.A., Spadaro J.A., Kramer S., Becker R.O., Silver Anode treatment of chronic osteomyelitis, Clin Orthop, 1961:105, 1981.
62.Spadaro J.A., Webster D.A., Becker R.O., Silver Polymethyl methacrylate antibacterial bone cement, Clinical Orthop, 143:266, 1979.
63.Schriber, William J., M.A., M.D., Lea & Febiger, A Manual of Electrotherapy, 1978.
64.Becker R.O., Spadaro J.A., Treatment of Orthopedic Infections with Electrically Generated Silver Ions J. Bone Jt. Surgery, 60-A:871, 1978.
65.Science Digest, “Silver – New Magic in Medicine”, March 1978.
66.Berg, A.O., Placebos: A Brief Review for Family Physicians, J. Fam. Pract., 1977, July; 5(1):97-100.
67.Downer, Ann, B.A., M.A., L.P.T., Physical Therapy Procedures: Selected Techniques, Charles C Thomas Publisher, 1977.
68.Boericke, William, M.D., Sett Dey & Co., Materia Medica with Repertory, Calcutta, 1976.
69.Gillman, A., Goodman, L.S., The Pharmacological Basis of Therapeutics, 5th ed. New York,: Macmillan, 1975:930-1.
70.Krusen, Frank H., M.D., Kottke, Frederic J., M.D., PhD., Ellwood, Paul M. Jr., M.D. Handbook of Physical Medicine and Rehabilitation, W.B. Saunders Company, 1971.
71.William R. Hill, M.D. & Donald M. Pillsbury, M.A., M.D., The Williams & Wilkins Company, “ARGYRIA – The Pharmacology of Silver”, 1939.
72.Sheldon, J.H., M.D., The British Medical Journal, Jan 13, 1934, p. 47-58.
73.(1931) Index-Catalogue of the Library of the Surgeon General’s Office United States Army, United States Printing Office, Washington, V. IX, p. 628.
74.Shouse, Samuel S., M.D., and Whipple, George H., M.D., “Effects of the Intravenous Injection of Colloidal Silver upon the Hematopoeitic System in Dogs”, Journal of Experimental Medicine, 53, p. 413-419, 1931.
75.Gettler, A.O., et. al., A Contribution to the pathology of generalized argyria with a discussion of the fate of silver in the human body, Am J Pathol 1927;3:631-52.
76.Demant, P., Journal of the American Medical Association, “Blocking the Reticulo-endothelial system and Glycemia”, p. 916, 87 (23) Dec. 4, 1926.
77.Searle, Albert B., Constable & Company LTD, “The Use of Colloids in Health and Disease” London, 1919.
78.Bechhold, H., (1919), Colloids in biology and medicine, translated by J.G.M. Bullow. D. Nostrand Company: New York, (page 367).
79.Searle, A.B., (1919), The use of Colloids in Health and Disease, (Quoting from the British Medical Journal, May 12, 1917), E.P. Dutton & Company, New York) p. 82.
80.Sanderson-Wells, T.H., M.D., “A Case of Puerperal Septicaemia Successfully Treated with Intravenous Injections of Collosol Argentum”, Lancet, Feb. 16, 1916.
81.Brown, G. Van Amber, M.D., “Colloidal Silver in Sepsis”, Journal of the American Association of Obstetricians and Gynecologists, Jan, 1916.
82.Marshall, C.R. M.D., and Killoh, G.B. M.D., “The Bactericidal Action of Collosols of Silver and Mercury”, British Medical Journal, Jan 16, 1915.
83.Roe, Legge A., “Collosol Argentum and its Ophthalmic uses”, British Medical Journal, Jan 16, 1915.
84.Simpson, W. J. M.D., “Experiments on the Germicidal Action of Colloidal Silver”, Lancet, Dec. 12, 1914.
85.Castle, James, M.D., “Some Recent Observations on Sprue”, British Medical Journal, nov. 15, 1912.
86.Duhamel, B. G. M.D., “Electric Metallic Colloids and their Therapeutical Applications”, Lancet, Jan 13, 1912.
87.MacLeod, Alex O. E., “Electric Metallic Colloids and their Therapeutical Applications”, Lancet, Feb 3, 1912.
Signature illegible
Prof. Dr. Tomislav Jovanovic
http://www.silvermedicine.org/nebulizers.html

Nebulizer & glutathione: I have found nebulized glutathione to be incredible for my lungs. I have been doing glutathione IV's for mopping up toxins from lyme disease. I started doing nebulized glutathione to get it in my blood between IV's. I recently had a cold and in the past it always caused a severe lung infection and bronchitis. It would take months to get back to normal. With the glutathione inhalation, there was much less sign of lung infection, and the bronchitis was so minimal, I was back to normal in 2-3 weeks instead of months. Source